Both the S&P 500 and Nasdaq Composite indexes are hovering around all-time highs. Unsurprisingly, a euphoric narrative ...

About This EventADMA Biologics, Inc. (Nasdaq: ADMA), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, visits the ...

Meta's operating performance has been incredibly strong over the past year, thanks partly to its investments in AI, so its ...

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024.

Nvidia owns a 7% stake in CoreWeave, and made it possible for the young company to be the first to launch its latest GPUs. In ...

One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) looks like an absolute steal compared to Palantir. While Palantir's forward price-to-earnings ratio is a jaw-dropping 256.4, Alphabet's shares ...

Although Alibaba stock looks reasonably priced, Amazon's lower business risk from the U.S.-China tensions gives it the edge ...

Palantir bulls point to this as a reason why the stock could reach a $1 trillion valuation by 2035. However, the bears have ...

With shares down 21% year to date, Tesla (NASDAQ: TSLA) is reeling from a combination of weakening electric vehicle (EV) ...